TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Klerfalk Pharma AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,069
|
1,139
|
1,639 |
| Financial expenses |
2,968
|
537
|
3,105 |
| Earnings before taxes |
171
|
-343
|
6,804 |
| EBITDA |
74
|
172
|
606 |
| Total assets |
11,706
|
11,636
|
12,106 |
| Current assets |
664
|
1,215
|
1,687 |
| Current liabilities |
368
|
469
|
558 |
| Equity capital |
11,228
|
11,044
|
11,438 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
95.9%
|
94.9%
|
94.5% |
| Turnover per employee |
1,069
|
1,139
|
1,639 |
| Profit as a percentage of turnover |
16.0%
|
-30.1%
|
415.1% |
| Return on assets (ROA) |
26.8%
|
1.7%
|
81.9% |
| Current ratio |
180.4%
|
259.1%
|
302.3% |
| Return on equity (ROE) |
1.5%
|
-3.1%
|
59.5% |
| Change turnover |
-70
|
-500
|
522 |
| Change turnover % |
-6%
|
-31%
|
47% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.